Why the study?
What is the prevalence, clinical features, and prognostic effect of aspirin resistance in patients with acute coronary syndrome?
What is the prevalence, clinical features, and prognostic effect of aspirin resistance in patients with acute coronary syndrome?
Aspirin resistance occurs in approximately 11% of ACS patients taking 100 mg/day and is linked to increased inflammation and worse clinical prognosis.
No takes yet. Share an insight, caveat, or question.
May identify higher-risk ACS patients; hypothesis-generating for testing or targeted therapies, should not yet change practice.
Frolova et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: